共 14 条
[1]
[2]
[3]
[4]
[5]
[7]
[9]
The preclinical pharmacology of roflumilast – A selective; oral phosphodiesterase 4 inhibitor in development for chronic obstructive pulmonary disease.[J].Armin Hatzelmann;Esteban J. Morcillo;Giuseppe Lungarella;Serge Adnot;Shahin Sanjar;Rolf Beume;Christian Schudt;Hermann Tenor.Pulmonary Pharmacology & Therapeutics.2010, 4

